# The Gilenya Pregnancy Registry

> **NCT01285479** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 312 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Fingolimod

## Key facts

- **NCT ID:** NCT01285479
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10-15
- **Primary completion:** 2024-05-29
- **Final completion:** 2024-05-29
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01285479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01285479, "The Gilenya Pregnancy Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01285479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*